ABSTRACT
OBJECTIVE: The purpose of our study was to investigate the effect of adipose-derived stem cells (ASCs), endothelial-differentiated ASCs (EC/ASCs), and various conditioned media (CM) on wound healing in a diabetic swine model. We hypothesized that ASC-based therapies would accelerate wound healing. METHODS: Diabetes was induced in four Yorkshire swine through intravenous injection of streptozotocin. ASCs were harvested from flank fat and cultured in either M199 or EGM-2 medium. A duplicate series of seven full-thickness dorsal wounds were surgically created on each swine. The wounds in the cellular treatment group underwent injection of low-dose or high-dose ASCs or EC/ASCs on day 0, with a repeat injection of one half of the initial dose on day 15. Wounds assigned to the topical CM therapy were covered with 2 mL of either serum-free M199 primed by ASCs or human umbilical vein endothelial cells every 3 days. Wounds were assessed at day 0, 10, 15, 20, and 28. The swine were sacrificed on day 28. ImageJ software was used to evaluate the percentage of wound healing. The wounded skin underwent histologic, reverse transcription polymerase chain reaction, and enzyme-linked immunosorbent assay examinations to evaluate markers of angiogenesis and inflammation. RESULTS: We found an increase in the percentage of wound closure rates in cell-based treatments and topical therapies at various points compared with the untreated control wounds (P < .05). The results from the histologic, messenger RNA, and protein analyses suggested the treated wounds displayed increased angiogenesis and a diminished inflammatory response. CONCLUSIONS: Cellular therapy with ASCs, EC/ASCs, and topical CM accelerated diabetic wound healing in the swine model. Enhanced angiogenesis and immunomodulation might be key contributors to this process.
Subject(s)
Adipose Tissue/cytology , Cell Differentiation , Culture Media, Conditioned/pharmacology , Diabetes Mellitus, Experimental/complications , Endothelial Progenitor Cells/transplantation , Multipotent Stem Cells/transplantation , Skin/blood supply , Wound Healing , Wounds, Penetrating/therapy , Administration, Topical , Animals , Cell Differentiation/drug effects , Cells, Cultured , Culture Media, Conditioned/metabolism , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Endothelial Progenitor Cells/metabolism , Gene Expression Regulation , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Male , Multipotent Stem Cells/metabolism , Neovascularization, Physiologic , Phenotype , Skin/drug effects , Skin/injuries , Skin/metabolism , Sus scrofa , Time Factors , Wound Healing/drug effects , Wounds, Penetrating/etiology , Wounds, Penetrating/metabolism , Wounds, Penetrating/pathologyABSTRACT
INTRODUCTION: Neoadjuvant chemotherapy prior to lumpectomy or mastectomy for breast cancer challenges wound healing. Suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, has been shown to work synergistically with paclitaxel in vitro and in preclinical studies. In addition, our laboratory has demonstrated that SAHA treatment decreases paclitaxel-associated stem cell toxicity, modulates inflammatory response, and promotes wound healing in injured fibroblast cells. Our goal was to determine if combined SAHA and paclitaxel treatment would improve wound healing in an in vivo full-thickness murine model, without altering antitumor effect. METHODS: Thirty-two nude athymic mice received intraperitoneal injections of paclitaxel (20 mg/kg), SAHA (25 mg/kg), paclitaxel + SAHA (20 mg/kg + 25 mg/kg), or no treatment for 2 weeks prior to surgery. Under general anesthesia, 8-mm full-thickness dorsal wounds were created in all animals, and a silicone splint was attached to minimize wound contraction. The wounds were measured twice a week with a surgical caliper until healing was complete. To evaluate the in vivo effect of drug treatment, 16 athymic nude mice with MDA-MB-231 xenografts received the treatments described previously, following which tumor volumes were compared between groups. RESULTS: Average wound healing time was prolonged in mice treated with paclitaxel (20 ± 1.9 days), and combination SAHA + paclitaxel therapy improved average wound healing time (17.0 ± 1.8 days). In the xenograft model, the antitumor effect of SAHA and paclitaxel (average tumor volume 43.9 ± 34.1 mm) was greater than paclitaxel alone (105.8 ± 73.8 mm). CONCLUSIONS: The addition of SAHA to taxane chemotherapy improves the therapeutic effect on triple-negative breast cancer while decreasing the detrimental effect of paclitaxel on wound healing. This may have substantial implications on improving outcomes in breast reconstruction following chemotherapy.
Subject(s)
Back Injuries/drug therapy , Histone Deacetylase Inhibitors/pharmacology , Paclitaxel/pharmacology , Vorinostat/pharmacology , Wound Healing/drug effects , Animals , Disease Models, Animal , Mice , Mice, NudeABSTRACT
Penetrating transmediastinal traumatic injuries often carry a high mortality given the vital structures this type of injury often involves. Here, we describe a case of 24-year-old man who suffered multiple stab wounds to the chest and back with associated cardiac, esophageal, and arterial injury, requiring immediate operative intervention. He underwent sternotomy and left thoracotomy with pericardiotomy, repair of 2 right ventricular lacerations, and ligation of internal mammary artery. The esophageal injury was repaired with endoscopic clips. Patient had an uncomplicated recovery. Despite high mortality often associated with transmediastinal penetrating injuries, good outcomes are achievable with rapid identification of injuries and appropriate operative intervention alongside adequate resuscitation.
Subject(s)
Abdominal Injuries , Heart Injuries , Multiple Trauma , Thoracic Injuries , Vascular System Injuries , Wounds, Penetrating , Wounds, Stab , Abdominal Injuries/surgery , Adult , Heart Injuries/surgery , Humans , Male , Multiple Trauma/surgery , Thoracic Injuries/surgery , Wounds, Penetrating/surgery , Wounds, Stab/surgery , Young AdultABSTRACT
Background: Correct preoperative diagnosis of hepatobiliary disease can be challenging-even with current advances in radiographical imaging, laboratory testing, and endoscopic evaluation. Case presentation 1: A 65-year-old female with painless jaundice and weight loss was found to have cholelithiasis complicated by the Mirizzi syndrome. Case presentation 2: A 71-year-old female with new-onset painless jaundice and impacted stone in the gallbladder neck was found to have a cholangiocarcinoma. Case presentation 3: A 70-year-old male with progressive painless jaundice and weight loss was found to have a pancreatic adenocarcinoma. Conclusion: Proper diagnosis and management of patients with painless jaundice can be difficult in the preoperative setting and may require surgical exploration to obtain a definitive diagnosis.